Cécile Masson

11.3k total citations
34 papers, 524 citations indexed

About

Cécile Masson is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Cécile Masson has authored 34 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Genetics. Recurrent topics in Cécile Masson's work include CRISPR and Genetic Engineering (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and RNA modifications and cancer (4 papers). Cécile Masson is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and RNA modifications and cancer (4 papers). Cécile Masson collaborates with scholars based in France, Italy and United States. Cécile Masson's co-authors include Annarita Miccio, Tristan Félix, Mario Amendola, Fulvio Mavilio, Vasco Meneghini, M Audran, Marina Cavazzana, Alain Chevailler, C Pascaretti and Fatima Amor and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and Journal of the American Society of Nephrology.

In The Last Decade

Cécile Masson

33 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile Masson France 12 256 127 115 65 55 34 524
Carl Friedrich Classen Germany 17 206 0.8× 89 0.7× 120 1.0× 121 1.9× 79 1.4× 37 617
Iwona Auer Canada 13 114 0.4× 78 0.6× 118 1.0× 108 1.7× 126 2.3× 28 714
Simona Lucchi Italy 10 153 0.6× 102 0.8× 56 0.5× 106 1.6× 56 1.0× 18 495
Paramjeet Singh India 12 329 1.3× 85 0.7× 43 0.4× 34 0.5× 30 0.5× 26 741
Céline Villenet France 14 176 0.7× 58 0.5× 50 0.4× 98 1.5× 79 1.4× 31 472
Beryl Crossley United States 13 170 0.7× 181 1.4× 57 0.5× 41 0.6× 93 1.7× 22 796
Lucrezia della Volpe Italy 5 266 1.0× 98 0.8× 113 1.0× 43 0.7× 43 0.8× 10 468
MF Fey Switzerland 10 217 0.8× 90 0.7× 81 0.7× 188 2.9× 166 3.0× 20 639
Heiko Pfister Germany 9 209 0.8× 47 0.4× 93 0.8× 195 3.0× 18 0.3× 14 773
Beatrijs M. Lodde United States 11 140 0.5× 133 1.0× 41 0.4× 105 1.6× 34 0.6× 14 578

Countries citing papers authored by Cécile Masson

Since Specialization
Citations

This map shows the geographic impact of Cécile Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Masson more than expected).

Fields of papers citing papers by Cécile Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Masson. The network helps show where Cécile Masson may publish in the future.

Co-authorship network of co-authors of Cécile Masson

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Masson. A scholar is included among the top collaborators of Cécile Masson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Masson. Cécile Masson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stolzenberg, Marie‐Claude, Mélanie Parisot, Cécile Masson, et al.. (2024). Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome. Cell Death and Disease. 15(5). 315–315. 3 indexed citations
2.
3.
Brusson, Mégane, Anne Chalumeau, Oriana Romano, et al.. (2023). Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies. Molecular Therapy — Nucleic Acids. 32. 229–246. 11 indexed citations
4.
Boutaud, Lucile, Bettina Bessières, Christine Bole, et al.. (2022). Biallelic THOC6 pathogenic variants: Prenatal phenotype and review of the literature. Birth Defects Research. 114(10). 499–504. 5 indexed citations
5.
Picard, Jean‐Yves, G Morin, Mojgan Devouassoux‐Shisheboran, et al.. (2022). Persistent Müllerian duct syndrome associated with genetic defects in the regulatory subunit of myosin phosphatase. Human Reproduction. 37(12). 2952–2959. 5 indexed citations
6.
Chartier, Suzanne, Lucile Boutaud, Caroline Alby, et al.. (2021). Prenatal‐onset of congenital neuronal ceroid lipofuscinosis with a novel CTSD mutation. Birth Defects Research. 113(18). 1324–1332. 2 indexed citations
7.
Chalumeau, Anne, Tristan Félix, Antonio Casini, et al.. (2021). Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease. Molecular Therapy. 30(1). 145–163. 7 indexed citations
8.
9.
Weber, Leslie, Giacomo Frati, Tristan Félix, et al.. (2020). Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Science Advances. 6(7). 93 indexed citations
10.
Viollet, Louis, Kathryn J. Swoboda, Rong Mao, et al.. (2020). A novel pathogenic variant in DYNC1H1 causes various upper and lower motor neuron anomalies. European Journal of Medical Genetics. 63(12). 104063–104063. 5 indexed citations
11.
Fadlallah, Jehane, Bertrand Boisson, Aurore Pouliet, et al.. (2020). From Dysgammaglobulinemia to Autosomal-Dominant Activation-Induced Cytidine Deaminase Deficiency: Unraveling an Inherited Immunodeficiency after 50 Years. The Journal of Pediatrics. 223. 207–211.e1. 3 indexed citations
12.
Lattanzi, Annalisa, Vasco Meneghini, Giulia Pavani, et al.. (2018). Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements. Molecular Therapy. 27(1). 137–150. 98 indexed citations
13.
Cavallin, Mara, A. Millischer, Despina Moshous, et al.. (2017). Prenatal and postnatal presentations of corpus callosum agenesis with polymicrogyria caused by EGP5 mutation. American Journal of Medical Genetics Part A. 173(3). 706–711. 10 indexed citations
14.
Megahed, Hisham, Michaël Nicouleau, Giulia Barcia, et al.. (2016). Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population. Orphanet Journal of Rare Diseases. 11(1). 57–57. 24 indexed citations
15.
Buchbinder, David, Jeffrey R. Stinson, Diane J. Nugent, et al.. (2015). Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation. Journal of Allergy and Clinical Immunology. 136(3). 819–821.e1. 39 indexed citations
16.
Valence, Stéphanie, Karine Poirier, Nicolas Lebrun, et al.. (2013). Homozygous truncating mutation of the KBP gene, encoding a KIF1B-binding protein, in a familial case of fetal polymicrogyria. Neurogenetics. 14(3-4). 215–224. 21 indexed citations
17.
Bandt, Michel De, Serge Perrot, Cécile Masson, & Olivier Meyer. (1997). Systemic sclerosis and sarcoidosis, a report of five cases. Lara D. Veeken. 36(1). 117–119. 19 indexed citations
18.
Masson, Cécile, et al.. (1995). [Electrocardiographic anomalies in relation with infarction in the territory of the anterior choroid artery].. PubMed. 151(11). 670–3. 2 indexed citations
19.
Raphael, Jacques, Cécile Masson, D. Brunel, et al.. (1986). [The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases].. PubMed. 142(6-7). 613–24. 36 indexed citations
20.
Doury, P, et al.. (1983). [Diagnosis or electronic monitoring? A little-known technical problem].. PubMed. 12(2). 104–104. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl Friedrich Classen Breakdown of academic impact, for papers by Iwona Auer Breakdown of academic impact, for papers by Simona Lucchi Breakdown of academic impact, for papers by Paramjeet Singh Breakdown of academic impact, for papers by Céline Villenet Breakdown of academic impact, for papers by Beryl Crossley Breakdown of academic impact, for papers by Lucrezia della Volpe Breakdown of academic impact, for papers by MF Fey Breakdown of academic impact, for papers by Heiko Pfister Breakdown of academic impact, for papers by Beatrijs M. Lodde
Rankless by CCL
2026